Join PharmaDispatch
Subscribe
Login
Explore the Site
Home
Latest News
BioPharma
Australian Biotech
Other Health
Comment
Executive
'MyBioPharmaSpace'
Video
Podcast
Conference 2019
About
Contact
Subscribe
Search
Follow Us
LinkedIn
Twitter
Instagram
BioPharmaDispatch
Menu
June 17, 2026
Subscribe
Login
Home
Latest News
BioPharma
Australian Biotech
Other Health
Comment
Executive
'MyBioPharmaSpace'
Video
Podcast
Conference 2019
About
Contact
Subscribe
Search
Sign In
Login
Forgot password?
Contact Us
Suite 9214
4 Duff Place
Deakin
ACT
2600
t. 0408 492 937
e.
contact@dailydispatch.com.au
Latest Video
Most Read
AstraZeneca confirms pricing the issue, and acts to create a patient access program
June 16, 2026 - Latest News
When good policy becomes self defeating, Australia must at least have a discussion about the obvious solution
June 16, 2026 - Latest News
High Court to decide on patent‑term extensions for formulations as GBMA intervenes
June 15, 2026 - Latest News
Approach policy and pricing negotiations like planning for a product launch
June 15, 2026 - Latest News
Paradigm reaches global milestone as Phase 3 osteoarthritis trial completes enrolment
June 15, 2026 - Australian Biotech
Follow Us
LinkedIn
Twitter
Instagram
New Stories
Australian company partners to take innovative therapy to Asia
June 17, 2026 - - Latest News
Novartis names interim leader for Australia and NZ after Country President departs
June 17, 2026 - - Latest News
These outcomes are mostly about the choices Australia is making
June 17, 2026 - - Latest News
AstraZeneca confirms pricing the issue, and acts to create a patient access program
June 16, 2026 - - Latest News
When good policy becomes self defeating, Australia must at least have a discussion about the obvious solution
June 16, 2026 - - Latest News
Entropy Neurodynamics clears safety hurdle for IV psilocin trial in binge eating disorder
June 15, 2026 - - Australian Biotech
Paradigm reaches global milestone as Phase 3 osteoarthritis trial completes enrolment
June 15, 2026 - - Australian Biotech